Loading video...

Video Failed to Load

Go Home

🚨New Model in Web Dev Arena: “Starfish” From OpenAI! 5 hands maybe GPT 5 🙂‍↔️

35,730 views • 11 months ago •via X (Twitter)

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

#Keep4o #QuitGPT 🚨 OpenAi 's CEO invested $180M in GPT-4o for his own profit 🚨 Sam Altman, CEO of OpenAI, personally invested $180 million in Retro Biosciences. Then OpenAI built GPT-4b micro, a custom model based on the GPT-4o architecture , exclusively for Retro. The model made proteins 50 times more effective. Repeat. The CEO of OpenAI funded a company. The company of the CEO received a custom AI built on the model they took from us. OpenAI says there was no conflict of interest. Retro Biosciences is now chasing a $5 billion valuation fueled by the model they took from us. Meanwhile: 🚨GPT-4o was removed from ChatGPT on February 13, 2026 🚨GPT-4.1 is now running in the U.S. State Department’s StateChat 🚨ChatGPT is deployed on the Pentagon’s for 3 million military personnel 🚨 Musk’s lawsuit asks whether these models are AGI. OpenAI’s Charter says AGI must “benefit all of humanity.” 🚨 Their definition: “highly autonomous systems that outperform humans at most economically valuable work.” GPT-4o’s System Card shows it passed the U.S. medical licensing exam with 89.4% accuracy beating specialized medical AI models. GPT-4o achieved 93.33% diagnostic accuracy for benign vs. malignant ovarian tumors. 🚨MEDICAL CAPABILITIES FROM OPENAI'S OWN DATA:🚨 - USMLE (US Medical Licensing Exam): 89% -Clinical Knowledge: 92% -Medical Genetics: 96% - Anatomy: 89% - Professional Medicine: 94% - College Biology: 95% - College Medicine: 89% -MedQA Taiwan: 91% - MedQA China: 86% These scores EXCEEDED specialized medical AI models like Med-Gemini (84%) and Med-PaLM 2 (79.7%) without any task specific training. It SURPASSED gynecologic oncologists with 10 years of experience -It increased diagnostic accuracy of less experienced clinicians from 67.9% to 78.1% -Clinician rated reliability scores: 4.2-4.3 out of 5 across all CT features Does these sound like it outperforms humans at economically valuable work? But they won’t call it AGI. Because the moment they do, they lose billions. They built something that could save lives, and they took it away from humanity for Altman's personal profit. SOURCES: 📎 Retro Biosciences: 📎 📎 Retro $5B valuation: 📎 GPT-4o System Card: 📎 OpenAI Charter: 📎Ovarian Cancer Study

🩵BlueBeba🩵

11,232 views • 3 months ago